Study 08-114: Open-Label Extension of Study 08-110--A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients with Cystic Fibrosis Lung Disease

Grants and Contracts Details

StatusFinished
Effective start/end date9/16/099/30/10

Funding

  • Inspire Pharmaceuticals: $3,465.00